vs
Side-by-side financial comparison of Kornit Digital Ltd. (KRNT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Kornit Digital Ltd. is the larger business by last-quarter revenue ($143.1M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $8.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.6%).
Kornit Digital Ltd. is an Israeli-American international manufacturing company. It produces high-speed industrial inkjet printers, pigmented ink and chemical products for the garment and apparel, home goods, textile accessories and decorating industry.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
KRNT vs PBYI — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.1M | $75.5M |
| Net Profit | $-19.0M | — |
| Gross Margin | 42.4% | 69.3% |
| Operating Margin | -25.2% | 22.7% |
| Net Margin | -13.3% | — |
| Revenue YoY | — | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.5M | ||
| Q3 25 | $143.1M | $54.5M | ||
| Q2 25 | $92.4M | $52.4M | ||
| Q1 25 | $43.8M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | $163.2M | $80.5M | ||
| Q2 24 | $104.0M | $47.1M | ||
| Q1 24 | $47.8M | $43.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-19.0M | $8.8M | ||
| Q2 25 | $-18.1M | $5.9M | ||
| Q1 25 | $-13.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-41.4M | $20.3M | ||
| Q2 24 | $-33.3M | $-4.5M | ||
| Q1 24 | $-18.9M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | 42.4% | 77.7% | ||
| Q2 25 | 39.4% | 76.5% | ||
| Q1 25 | 32.3% | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | 32.1% | 63.9% | ||
| Q2 24 | 30.6% | 77.4% | ||
| Q1 24 | 27.4% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -25.2% | 17.6% | ||
| Q2 25 | -31.4% | 12.7% | ||
| Q1 25 | -41.8% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | -36.6% | 27.4% | ||
| Q2 24 | -43.3% | -4.6% | ||
| Q1 24 | -50.5% | -5.3% |
| Q4 25 | — | — | ||
| Q3 25 | -13.3% | 16.2% | ||
| Q2 25 | -19.6% | 11.2% | ||
| Q1 25 | -30.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -25.4% | 25.2% | ||
| Q2 24 | -32.0% | -9.6% | ||
| Q1 24 | -39.6% | -11.0% |
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $35.0M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | — | $130.3M |
| Total Assets | $787.5M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | $35.0M | $94.4M | ||
| Q2 25 | $35.0M | $96.0M | ||
| Q1 25 | $35.0M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | $39.6M | $96.7M | ||
| Q2 24 | $39.6M | $96.8M | ||
| Q1 24 | $39.6M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | — | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
| Q4 25 | — | $216.3M | ||
| Q3 25 | $787.5M | $202.9M | ||
| Q2 25 | $787.5M | $194.9M | ||
| Q1 25 | $787.5M | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | $865.6M | $220.7M | ||
| Q2 24 | $865.6M | $205.0M | ||
| Q1 24 | $865.6M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.1M | $14.4M |
| Free Cash FlowOCF − Capex | $8.8M | $14.4M |
| FCF MarginFCF / Revenue | 6.2% | 19.1% |
| Capex IntensityCapex / Revenue | 9.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.4M | ||
| Q3 25 | $22.1M | $9.7M | ||
| Q2 25 | $8.5M | $14.1M | ||
| Q1 25 | $4.0M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | $8.8M | $9.7M | ||
| Q2 25 | $5.8M | $14.1M | ||
| Q1 25 | $2.7M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | 6.2% | 17.7% | ||
| Q2 25 | 6.3% | 26.8% | ||
| Q1 25 | 6.3% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 9.2% | 0.0% | ||
| Q2 25 | 2.9% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KRNT
| Products | $100.4M | 70% |
| Services | $42.8M | 30% |
PBYI
Segment breakdown not available.
